Legal Representation
Attorney
Caleb Norris
Application History
27 eventsDate | Code | Type | Description |
---|---|---|---|
Mar 29, 2024 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
Jun 12, 2022 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB |
May 21, 2022 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB |
May 20, 2022 | FIMP | P | FINAL DISPOSITION PROCESSED |
Apr 29, 2022 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
Feb 28, 2022 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Nov 30, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Sep 14, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION |
Sep 14, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Sep 14, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Sep 14, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Aug 26, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Aug 26, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Aug 26, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Aug 6, 2021 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
Aug 4, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Aug 3, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Aug 3, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Mar 22, 2021 | RFNT | P | REFUSAL PROCESSED BY IB |
Feb 27, 2021 | RFRR | P | REFUSAL PROCESSED BY MPU |
Feb 27, 2021 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Feb 25, 2021 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Feb 24, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN |
Feb 23, 2021 | DOCK | D | ASSIGNED TO EXAMINER |
Nov 10, 2020 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
Nov 6, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Nov 5, 2020 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Detailed Classifications
Class 005
Pharmaceuticals and pharmaceutical preparations for treating osteoarticular diseases; dietary, nutritional, mineral, dietary nutraceutical, and vitamin supplements and preparations for medical purposes; dietary enzyme and protein supplements; dietetic food and preparations adapted for medical purposes; all the aforesaid goods for use in the osteoarticular field
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of a shaded hexagon carrying the image of a human foot. To the right of the hexagon, the stylized wording "DOLTENDIX" appears.
Classification
International Classes
005